Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Primary Objective: Determine blood concentrations of two formulations of REGN1033. Secondary Objective: Assess safety and tolerability of REGN1033.
Epistemonikos ID: 2612c5e9f5af542d45b40e98ff25ae4a888a8701
First added on: May 12, 2024